- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06210230
Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms
March 14, 2024 updated by: Yu Zhang, Zhejiang University
Double-blind and placebo-controlled study on intervention effect of medium and long chain fatty acid triglyceride on glycolipid homeostasis in patients with metabolic syndrome and mechanisms
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Jinhua, Zhejiang, China, 321102
- Lanxi Traditional Chinese Medicine Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed metabolic syndrome according to IDF diagnostic criteria;
- Rarely eating out of home;
- Aged between 40 and 70 years.
Exclusion Criteria:
- Breastfeeding or pregnancy;
- History of heart disease, coronary heart disease, stroke, cerebral infarction, viral liver disease (hepatitis A, hepatitis B, etc.), chronic kidney disease (GFR<60 ml/min) or cancer;
- Diabetic ketoacidosis or hyperketosis;
- Drug use has changed in the past six months;
- Taking insulin;
- Used MLCT edible oil in the past six months;
- Have participated in other clinical trials in the last three months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
|
MLCT 25g/d for 6 months
|
Placebo Comparator: Control group
|
Matching placebo (olive oil) 25g/d for 6 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in blood glucose from baseline
Time Frame: 6 months
|
The investigators will measure HbA1c and fasting plasma glucose levels in blood samples before and after treatment.
|
6 months
|
Change in blood lipids from baseline
Time Frame: 6 months
|
The investigators will measure Triglycerides (TG), total cholesterol (TC), LDL-C, and HDL-C levels in blood samples before and after treatment.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 22, 2023
Primary Completion (Actual)
November 22, 2023
Study Completion (Actual)
December 10, 2023
Study Registration Dates
First Submitted
January 6, 2024
First Submitted That Met QC Criteria
January 6, 2024
First Posted (Actual)
January 18, 2024
Study Record Updates
Last Update Posted (Actual)
March 18, 2024
Last Update Submitted That Met QC Criteria
March 14, 2024
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCT_MLCT_MetS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
Mayo ClinicCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia
Clinical Trials on Olive oil
-
Harvard School of Public Health (HSPH)CompletedCardiovascular Disease
-
Minia UniversityRecruitingOrthodontic Tooth MovementEgypt
-
Spanish National Research CouncilAndalusian Health Service; Universidad Pablo de OlavideRecruitingType II Diabetes Mellitus | Diabetic PatientsSpain
-
University of LimerickCompletedCardiovascular Diseases | Obesity | DiabetesIreland
-
Université Catholique de LouvainCompleted
-
Javad NasrollahzadehShahid Beheshti University of Medical SciencesCompletedCardiovascular Risk FactorIran, Islamic Republic of
-
University of BarcelonaHospital Clinic of Barcelona; Institut d'Investigacions Biomèdiques August...Completed
-
Hospital General Nuestra Señora del PradoCompleted
-
Griffin HospitalCompletedType 2 DiabetesUnited States
-
University of California, DavisActive, not recruitingHealthy | Overweight | Obese | Normal WeightUnited States